Fred E Cooperrider

Array ( [id] => 132262 [patent_doc_number] => 07695902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => utility [patent_app_number] => 10/078949 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 32417 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695902.pdf [firstpage_image] =>[orig_patent_app_number] => 10078949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801234 [patent_doc_number] => 20030096399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Substantially complete ribozyme libraries' [patent_app_type] => new [patent_app_number] => 10/067956 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 50705 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096399.pdf [firstpage_image] =>[orig_patent_app_number] => 10067956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537860 [patent_doc_number] => 20020137186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Lymphotropic agents and vectors' [patent_app_type] => new [patent_app_number] => 10/061393 [patent_app_country] => US [patent_app_date] => 2002-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 7808 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137186.pdf [firstpage_image] =>[orig_patent_app_number] => 10061393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345126 [patent_doc_number] => 07498313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Large circular target-specific antisense nucleic acid compounds' [patent_app_type] => utility [patent_app_number] => 10/066498 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12673 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498313.pdf [firstpage_image] =>[orig_patent_app_number] => 10066498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797502 [patent_doc_number] => 20030176376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof' [patent_app_type] => new [patent_app_number] => 10/053645 [patent_app_country] => US [patent_app_date] => 2002-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25891 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176376.pdf [firstpage_image] =>[orig_patent_app_number] => 10053645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754121 [patent_doc_number] => 07018832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Human N-type calcium channel isoform and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/033026 [patent_app_country] => US [patent_app_date] => 2001-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26289 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018832.pdf [firstpage_image] =>[orig_patent_app_number] => 10033026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628207 [patent_doc_number] => 20020086396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Human transcription factor IIA' [patent_app_type] => new [patent_app_number] => 10/023650 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10007 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086396.pdf [firstpage_image] =>[orig_patent_app_number] => 10023650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743096 [patent_doc_number] => 20060088821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components' [patent_app_type] => utility [patent_app_number] => 10/034622 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19250 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088821.pdf [firstpage_image] =>[orig_patent_app_number] => 10034622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545234 [patent_doc_number] => 20020137715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis' [patent_app_type] => new [patent_app_number] => 10/026341 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8657 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137715.pdf [firstpage_image] =>[orig_patent_app_number] => 10026341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852020 [patent_doc_number] => 20030144223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Antisense modulation of connective tissue growth factor expression' [patent_app_type] => new [patent_app_number] => 10/006191 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144223.pdf [firstpage_image] =>[orig_patent_app_number] => 10006191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668930 [patent_doc_number] => 20030113914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Antisense modulation of CD81 expression' [patent_app_type] => new [patent_app_number] => 10/006430 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25626 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113914.pdf [firstpage_image] =>[orig_patent_app_number] => 10006430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791897 [patent_doc_number] => 20030087241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Circular DNA vectors for synthesis of RNA and DNA' [patent_app_type] => new [patent_app_number] => 09/997931 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 28814 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087241.pdf [firstpage_image] =>[orig_patent_app_number] => 09997931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958713 [patent_doc_number] => 06953657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Molecules of the CARD-related protein family and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/996617 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32451 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953657.pdf [firstpage_image] =>[orig_patent_app_number] => 09996617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697273 [patent_doc_number] => 20030109467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Antisense modulation of human FXR expression' [patent_app_type] => new [patent_app_number] => 10/002491 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24898 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109467.pdf [firstpage_image] =>[orig_patent_app_number] => 10002491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651290 [patent_doc_number] => 20030105040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense modulation of inhibitor-kappa B-R expression' [patent_app_type] => new [patent_app_number] => 09/993731 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25353 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105040.pdf [firstpage_image] =>[orig_patent_app_number] => 09993731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667607 [patent_doc_number] => 20060172957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Antisense modulation of integrin beta 4 binding protein expression' [patent_app_type] => utility [patent_app_number] => 10/415324 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25002 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172957.pdf [firstpage_image] =>[orig_patent_app_number] => 10415324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851007 [patent_doc_number] => 20030143210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/040281 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20568 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143210.pdf [firstpage_image] =>[orig_patent_app_number] => 10040281 [rel_patent_id] =>[rel_patent_doc_number] =>)